US Stock MarketDetailed Quotes

DNTH Dianthus Therapeutics

Watchlist
  • 21.755
  • +0.305+1.42%
Trading Apr 29 12:38 ET
698.90MMarket Cap-8.53P/E (TTM)

Dianthus Therapeutics Key Stats

Dianthus Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 910.700K--
--2025/Q1-- / 806.900K--
--2024/Q41.325M / 859.700K--
--2024/Q32.172M / 576.440K--
--2024/Q21.863M / 322.750K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 910.700K--
--2025/Q1-- / 806.900K--
--2024/Q41.325M / 859.700K--
--2024/Q32.172M / 576.440K--
--2024/Q21.863M / 322.750K--

Unlock Free Earnings Estimates

Dianthus Therapeutics Earnings Reports

Read more

Market Insights

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More